Partnering
Partnering to drive innovation and deliver new medicines
Antibody Platforms
Let’s build the future of medicine together
Collaboration is at the heart of our approach. By partnering with Large Biopharma, Small and Medium Biotech, Entrepreneurs, VC, Non-Profits, and Academics, we combine diverse expertise, perspectives, and resources to tackle complex challenges. Together, we drive innovation and achieve impactful results that would be difficult to accomplish alone.
Leading with innovation
Access to cutting-edge technology with a proven track record of success.
Expertise-driven solutions
Tailored solutions to meet your needs with continuous support and collaboration.
Driving drug discovery as a true collaborator and active partner
Consistently delivering therapeutic leads
With over 170 partners, 60+ licensed programs, and 9 antibodies in clinical development, Alloy has a proven history of delivering high-quality drug leads that meet our partners’ target product profile. We regularly tackle our partners’ most challenging targets and complex problems to unlock new possibilities in therapeutic antibody development.
Pushing the boundaries of drug discovery with novel platforms and services
We are on the forefront of innovation and working hard to stay ahead of the curve. Our commitment to reinvesting 100% of our revenue into innovation means we are always developing new groundbreaking platforms and protocols to make our collaborators more successful. Access our innovative platforms and let’s work together to push the boundaries of drug discovery.
Expertise at your fingertips to solve the most difficult challenges
Specializing in delivering tailored approaches, we are redefining what’s possible in drug discovery and development. Our seasoned experts and scientists bring a wealth of experience and novel techniques to ensure successful outcomes. In addition to our internal knowledge, we leverage our external relationships – the Alloy ecosystem – to put you on the right track as you accelerate to the clinic. Whether it’s NewCo creation, CDMO capabilities, or preclinical services, Alloy has the network.
Empowering discovery with accessible terms and collaborative approaches
Alloy Therapeutics provides innovative platforms and services designed to meet the evolving needs of our partners. By offering flexible, creative terms, we empower drug developers to accelerate discovery and development. Our collaborative approach ensures that partners have the tools, resources, and expertise needed to drive therapeutic innovation across modalities.
Start your journey with us
Latest News and Resources
